DRTS - Kewajiban jangka dawa perusahaan Alpha Tau Medical Ltd

This long-term liability chart for Alpha Tau Medical Ltd. (DRTS) illustrates the financial profile of a company that integrates ESG principles into the development of alpha-therapy systems and strictly adheres to bioethical standards. The current figure is 0.01. The company has outsourced the production of mechanical components, while key radiation developments remain in-house. The business specializes in innovative targeted irradiation, integrating its proprietary solutions into clinical protocols.

Long-term debt records the total volume of borrowed funds with maturities exceeding twelve months, determining the issuer's financial stability. The dynamics of a company's long-term debt allow for a real-time assessment of debt service costs under tight monetary policy conditions. This metric measures default risk through the ratio of credit load to equity. For Alpha Tau Medical Ltd. (DRTS), such a borrowing structure remains stable due to the non-cyclical nature of cancer therapy development.